Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Eur Respir J. 2016 Oct 6;48(5):1340–1350. doi: 10.1183/13993003.00823-2016

TABLE 3.

Physiology parameters during placebo and desipramine night (n=14)

Placebo Desipramine p-value
Veupnoea L·min−1 7.3 (1.6) 7 (1.3) >0.5
Varousal L·min−1 4.8 (1.9) 5.4 (2.3) 0.1
V0,active L·min−1 2.5 (3.2) 4.0 (3.4) 0.33
V0,passive L·min−1 0.7 (2.6) 1.0 (2.0) 0.39
VeupnoeaVarousal L·min−1 2.7 (1.4) 1.8 (1.7) 0.07
VarousalV0,active L·min−1 2.1 (4.4) 0.6 (4.2) 0.33
V0,activeV0,passive (muscle compensation) L·min−1 1.5 (2.9) 2.4 (3.7) 0.24

Data are presented data as median (interquartile range), unless otherwise stated. Veupnoea: eupnoeic ventilation; Varousal: ventilation that leads to arousals; V0,passive: ventilation at a nasal pressure of 0 cmH2O when the pharyngeal muscles are passive; V0,active: ventilation at a nasal pressure of 0 cmH2O when the pharyngeal muscles are active.